Search

A team at MSK led by thoracic surgeon Dr. Prasad Adusumilli has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors.

… Monday, March 18, 2024 A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD , has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy  for

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at the group's 147th annual meeting in April.

… Tuesday, June 1, 2010 Summary Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at the group’s 147th annual meeting in April. Charles L. Sawyers , Chair of the Human Oncology and Pathogenesis Program (HOPP), was elected to the National

Learn how MSK helps cancer patients in underserved communities with technology, food, language interpretation, and more. Natasha Bhalla, an MSK patient with breast cancer, talks about the difference it's made for her.

… Thursday, November 2, 2023 Having stage 4 breast cancer and focusing on your treatment is hard enough. But cancer can also be expensive. Where do you turn when even the cost of healthy food is too much? When Natasha Bhalla was diagnosed with hormone receptor-positive breast cancer, she worried about

Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.

… Thursday, December 8, 2016 Summary Women undergoing mastectomy for breast cancer have two main options for reconstructive surgery : artificial implants or flap surgery using their own tissue. A new study looked at these options in women who received radiation after mastectomy and found that those whose

A new drug for ovarian cancer, which was developed based on lab research at MSK, is transforming the possibilities for patients like Ellen Coopersmith.

… Thursday, September 11, 2025 VIDEO | 02:38 Watch How a Lab Discovery Sparked New Treatment for Rare Ovarian Cancer Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the

The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, March 15, 2024 The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the  American Association for Thoracic Surgery and the  Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK). TSOG is a network of thoracic surgeons

The Peritoneal Surface Malignancies Consortium Group is a national, multidisciplinary collaboration of surgical and medical gastrointestinal oncology specialists from top cancer centers. The group recently published a series of updated consensus guidelines for the clinical management of peritoneal metastases related to a variety of gastrointestinal malignancies. In this Q&A with Dr. Michael Foote we discuss discuss the major updates for the management of colorectal cancer and appendiceal cancer peritoneal metastases and how the changes will improve patient outcomes and streamline patient care.

… Tuesday, December 23, 2025 A Q&A with  Michael Foote, MD , MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM Consortium Group) is a national, multidisciplinary collaboration of surgical

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 31, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Vinod Balachandran Awarded the 2023 FNIH Trailblazer Prize for Clinician-Scientists Vinod Balachandran, MD , hepatopancreatobiliary surgeon, was awarded the  2023 Trailblazer

MSK is a leader in developing new types of immunotherapy for gynecologic cancers, including tumors of the cervix, ovaries, and uterus.

… Wednesday, September 30, 2020 Summary MSK currently has a number of trials investigating the use of T cell therapies in gynecologic therapy — an approach that’s beginning to show promise in treating these and other solid tumors. The American Cancer Society estimates that more than 113,000 people in the

Stephen B. Long, PhD will share “Something Completely Different” during the June 17 edition of “MSK Science Spotlight” – the Structure and Mechanism in the Calcium-Activated Chloride Channel BEST1.

… Wednesday, June 17, 2020 Stephen B. Long , PhD will share “Something Completely Different” during the June 17 edition of “ MSK Science Spotlight ” – the Structure and Mechanism in the Calcium-Activated Chloride Channel BEST1. Head of the Stephen Long Lab and Member of the Structural Biology Program at